Eagle Pharmaceuticals shares owned by Barclays
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $155k | 30k | 5.24 |
| 2023-09-30 | $168k | 11k | 15.82 |
| 2023-06-30 | $490k | 25k | 19.47 |
| 2023-03-31 | $158k | 5.6k | 28.44 |
| 2022-12-31 | $1.0M | 34k | 29.22 |
| 2022-09-30 | $1.0M | 39k | 26.44 |
| 2022-06-30 | $153k | 3.4k | 44.48 |
| 2022-03-31 | $455k | 9.2k | 49.57 |
| 2021-12-31 | $759k | 15k | 50.85 |
| 2021-09-30 | $657k | 12k | 55.79 |
| 2021-06-30 | $273k | 6.4k | 42.81 |
| 2021-03-31 | $998k | 24k | 41.71 |
| 2020-12-31 | $1.2M | 26k | 46.55 |
| 2020-09-30 | $1.2M | 28k | 42.42 |
| 2020-06-30 | $659k | 14k | 47.94 |
| 2020-03-31 | $1.8M | 38k | 46.02 |
| 2019-12-31 | $1.3M | 22k | 60.10 |
| 2019-09-30 | $2.0M | 36k | 56.60 |
| 2019-06-30 | $1.7M | 31k | 55.67 |
| 2019-03-31 | $1.4M | 27k | 50.51 |
| 2018-12-31 | $852k | 21k | 40.30 |
| 2018-09-30 | $2.7M | 39k | 69.30 |
| 2018-06-30 | $817k | 11k | 75.69 |
| 2018-03-31 | $238k | 4.5k | 52.41 |
| 2017-12-31 | $976k | 18k | 53.37 |
| 2017-09-30 | $58k | 1.0k | 57.59 |
| 2017-06-30 | $2.3M | 30k | 78.83 |
| 2017-03-31 | $3.7M | 45k | 83.33 |
| 2016-12-31 | $14M | 180k | 79.34 |
| 2016-09-30 | $4.5M | 65k | 70.01 |
| 2016-06-30 | $4.9M | 126k | 38.79 |
| 2016-03-31 | $95k | 2.4k | 39.85 |
| 2015-12-31 | $238k | 2.7k | 87.62 |
| 2015-09-30 | $19k | 260 | 74.07 |
| 2015-06-30 | $13k | 164 | 79.27 |
| 2015-03-31 | $820k | 20k | 41.00 |
| 2014-09-30 | $999 | 42 | 23.81 |
| 2014-06-30 | $128k | 9.2k | 13.95 |
| 2014-03-31 | $1.0k | 91 | 10.99 |